Valuation: EMV Capital plc

Market Cap 14.4M 19.25M 16.82M 15.44M 27.31M 1.83B 27.77M 186M 72.07M 899M 72.27M 70.7M 3.1B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 13.37M 17.87M 15.62M 14.34M 25.35M 1.7B 25.78M 173M 66.92M 835M 67.11M 65.65M 2.88B EV / Sales 2026 *
3.9x
EV / Sales 2027 * 3.9x
Free-Float
52.15%
Yield 2026 *
-
Yield 2027 * -
1 day+0.97%
1 week+0.97%
Current month+0.97%
1 month+7.22%
3 months+0.97%
6 months-14.05%
Current year-8.77%
1 week 51
Extreme 51
52
1 month 48
Extreme 48
54.75
Current year 44
Extreme 44
62
1 year 40
Extreme 40
62
3 years 34
Extreme 34
80.5
5 years 34
Extreme 34
137
10 years 9.75
Extreme 9.75
846
Manager TitleAgeSince
Chief Executive Officer 51 2020-04-30
Director of Finance/CFO 45 2025-11-30
Chief Investment Officer - -
Director TitleAgeSince
Director/Board Member 51 2019-10-13
Director/Board Member 47 2022-12-08
Chairman 61 2023-01-31
Date Insider Type Main position Quantity % Market Cap.
01-07Sell 7,000 0.0250%
01-07Buy 7,000 0.0250%
12-18Sell

Director

34,484 0.1242%
Change 5-day change 1-year change 3-year change Capi.($)
+0.97%+0.97%+13.04%-16.13% 19.25M
+1.21%+5.46%+64.32%+25.81% 3.42B
+0.25%+4.72%-14.15%+7.84% 2.94B
0.00%+3.18%+44.42%+21.14% 2.01B
+0.99%+3.39%+83.67%+130.13% 1.23B
0.00%0.00%-1.72%-7.02% 720M
-10.82%-12.03%+155.46%+229.27% 605M
0.00%0.00%-44.78%-73.76% 407M
+2.10%+2.10%-2.67%-6.41% 399M
+2.33%+2.33%+0.46%-8.71% 374M
Average -0.31%+1.12%+29.81%+30.22% 1.21B
Weighted average by Cap. +0.08%+3.04%+36.65%+33.92%

Financials

2026 *2027 *
Net sales 3.43M 4.58M 4M 3.68M 6.5M 436M 6.61M 44.28M 17.16M 214M 17.21M 16.83M 737M 3.75M 5.01M 4.38M 4.02M 7.11M 477M 7.23M 48.45M 18.78M 234M 18.83M 18.42M 807M
Net income - -
Net Debt -1.03M -1.37M -1.2M -1.1M -1.95M -131M -1.98M -13.28M -5.15M -64.2M -5.16M -5.05M -221M 233K 311K 272K 250K 441K 29.62M 449K 3.01M 1.16M 14.53M 1.17M 1.14M 50.05M
Logo EMV Capital plc
EMV Capital plc is a United Kingdom-based deep tech and life sciences venture capital (VC) investment group with an international portfolio of companies. The Company identifies, invests in, and builds high-growth companies in the United Kingdom and internationally. It employs a capital-light investment approach, making use of its balance sheet and syndicating investments through its wholly owned VC subsidiary, EMV Capital Partners Limited. It secures a mixture of direct equity stakes and carried interest stakes in its portfolio of companies, creating a structure that can support a large portfolio. The Company has a portfolio of approximately 70 companies with a focus on life sciences, industrials, robotics & artificial intelligence (AI), and sustainability. Its subsidiaries include Glycotest, Inc., CetroMed Limited, NetScientific America, Inc., EMV Director Services Limited, EMV Capital Technology Limited, and ProAxsis Limited, among others.
Employees
21
Date Price Change Volume
26-07-03 GBX 52.00 +0.97% 37,946
26-07-02 GBX 51.50 0.00% 2,610
26-07-01 GBX 51.50 0.00% 112
26-06-30 GBX 51.50 0.00% 2
26-06-29 GBX 51.50 0.00% 0
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.5150GBP
Average target price
1.320GBP
Spread / Average Target
+156.31%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. EMVC Stock